Endometrial fertility. Management of adenomyosis in gynecology and infertility
Review
OA: closed
public-domain-us
Abstract
Adenomyosis has long been underrecognized, with limited evidence guiding its clinical management. In the last decade, the introduction of the Morphological Uterus Sonographic Assessment (MUSA) criteria and the growing recognition of its strong association with endometriosis have substantially changed the understanding of the disease. In women seeking pregnancy, treatment options remain challenging. Surgery is invasive, technically demanding, and associated with recurrence and potential obstetric risks, while hormonal therapies are incompatible with conception and have not demonstrated a benefit for infertility. IVF may overcome some adverse effects of adenomyosis on fertility, but its impact on embryo implantation remains problematic. Accordingly, available evidence suggests a possible reduction in live birth rates following IVF. However, current studies are limited by potential confounders. Studies investigating the use of medical pretreatment before IVF, including GnRH agonists, dienogest, or levonorgestrel-releasing intrauterine systems, remain insufficient and inconsistent. Further prospective studies and randomized controlled trials using standardized inclusion criteria are needed.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-11-21T06:17:04.340742+00:00
- openalex
- last seen: 2026-11-21T06:07:56.064915+00:00
- pubmed
- last seen: 2026-11-21T06:09:43.705417+00:00
- unpaywall
- last seen: 2026-11-21T07:40:41.001492+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine